Global Initiative on Health and the Economy
The Global Initiative on Health and the Economy (GIHE) champions public health, trade, and regulatory policies that enable companies in the healthcare sector to deliver solutions that benefit people around the world. We spotlight the unique value of the private sector and advocate for investment in public health as a means to directly drive economic resiliency and growth.
The Transformative Power of AI in Healthcare
As AI continues to revolutionize the healthcare sector, policymakers must collaborate with industry, ensuring effective AI for the global good.
Reports
Our views
- Digital health has the potential to address unmet medical needs Greater private and public investments to support new digital health tools is imperative for the advancement of global health. The public and private sector must work together to bridge the digital gaps present in societies and ensure that disadvantaged populations worldwide can benefit from new digital health tools. Read more
- Strengthening health systems leads to greater resiliency Not only will strong and resilient health systems withstand public health emergencies, but they will buffer economic losses and sustain growth. Resilient health systems protect against both infectious disease threats as well as rising chronic disease burdens.Read more
- Health investment drives economic growth Healthcare investments should be seen as a tool to grow the economy, rather than a budgetary cost. Non-communicable diseases and the ongoing COVID-19 pandemic represent two of the most serious drags on economic growth, and their broad impacts are growing rapidly.Read more
- Public-private partnerships are keyThere needs to be a trusted partnership with the private sector, whose role in health systems has been of critical importance during the pandemic via the development, production, and mass distribution of high-quality vaccines, therapeutics, diagnostics, and PPE. Read more
Latest Content
- At the World Health Assembly, the Chamber added to the global dialogue around sustainable manufacturing for health products and technologies through a focus on regulatory harmonization.Latin America's transition to Value Based Healthcare will require a comprehensive approach that includes policy reforms, infrastructure investment, and stakeholder collaboration.As AI continues to revolutionize the healthcare sector, policymakers must collaborate with industry, ensuring effective AI for the global good.Coordinated global action, with strong leadership from Capitol Hill, is critical to combating the threat of antimicrobial resistance (AMR).At the G20 Health Ministers Meeting, the Chamber explored innovative strategies to strengthen health systems and improve socioeconomic outcomes across the region.Countries seeking to improve equitable access to health products and technologies should look beyond local manufacturing.The Chamber commissioned a white paper on the barriers to unlocking innovative financing for UHC more effectively, and how to foster better collaboration among national governments, international development agencies, and the private sector. It is our hope that after reading this report, policymakers and development agencies will understand how to better crowd-in, leverage and enable the private sector.The Chamber commissioned a white paper on how the private sector should engage to support global policymakers in the advancement of digital health. This reports incorporates the perspectives of industry leaders, standard setting organizations, and multilateral agencies to provide policymakers with well-grounded recommendations in support of an efficient, impactful and equitable transformation of the health sector.On the margins of the Africa Leaders Summit that took place in December 2022, USTDA launched the Coalition for Healthcare Infrastructure in Africa. In partnership with other associations, the Chamber has signed onto USTDA’s coalition.
